Innovative BioTherapies (IBT) is a small biotechnology company located in Ann Arbor, MI, focused on developing medical devices to solve unmet medical needs. Our company has a talented and dedicated R&D team, which has patented several novel devices including the Selective Cytopheretic Device (SCD) currently in clinical use to treat inflammatory disease conditions including Acute Kidney Injury (AKI), Acute Respiratory Distress Syndrome (ARDS) and Multiple Organ Dysfunction (MOD) caused by various etiologies ranging from sepsis to COVID-19.